Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.

SHEL secures dismissal of a $58M lawsuit filed against it, affirming jurisdictional boundaries for international business disputes.

Computex, a trade show traditionally focused on consumer technology and new laptops, typically wouldn't be the place to announce big shifts in artificial-intelligence infrastructure and data centers. But this year, Nvidia NVDA+0.78% used the moment to introduce another way for the company to maintain its leadership.

GN Store Nord A/S hereby announces that on May 22, 2025, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on May 21, 2025, BlackRock, Inc. increased its aggregate direct and indirect holding of shares and financial instruments, cf. Section 38 and Sections 39(2)(1) and (2) of the Danish Capital Markets Act, to above 5% of the share capital and voting rights in GN Store Nord A/S.

The software company reported mixed but solid earnings and reiterated its full-year guidance.

Platinum prices are gaining momentum after years of underperformance. On May 21, 2025, spot platinum rose by $18 an ounce to $1,076, following a 5% hike on May 20, per Bloomberg data, as quoted on barrons.com.

Shares of Apple were under pressure on Friday after Trump's post on Truth Social.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your SoundHound AI, Inc. (NASDAQ:SOUN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/soundhound-ai-inc-lawsuit-submission-form?prid=149906&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Navitas' partnership with Nvidia on next-gen power infrastructure is a major catalyst, positioning Navitas as a key player in data center innovation. While profitability remains a few years away, shrinking losses and a strong cash position support my continued buy rating on NVTS. Adoption of Navitas' new GaN integrated circuits and the Nvidia deal are expected to drive future revenue and accelerate the path to profitability.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=149908&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

Home improvement retailer, Lowe's, recently reported mixed Q1 results, with a miss on revenues but a beat on earnings. Strong sales trends in the Pro unit remained prevalent in Q1, and this remains a key growth driver for the retailer in the quarters ahead. Full-year guidance was reaffirmed, sending shares higher initially following the release.

Long-term stock investing works. Historically, holding for 20+ years has never led to losses. I want more than just average returns, so I aim higher. I avoid ETFs and prefer concentrated bets in sectors I know well. My focus is on high-conviction picks I believe can double far faster than the market. In this article, I'm sharing three dividend stocks that are higher-risk, higher-reward. Even if I'm wrong, I believe they're still solid long-term investments.

PHILADELPHIA and VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announces the presentation of positive survival and clinical benefit data in three clinical poster presentations and one publish-only abstract at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 – June 3 at McCormick Place, Chicago, IL.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/solaris-energy-infrastructure-inc-lawsuit-submission-form?prid=149905&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149907&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

Western energy supermajors have long sought to return cash to investors through buyback programs and dividends to keep shareholders happy. Some analysts have raised doubts about the sustainability of Big Oil's pledge to allocate cash to shareholders after a drop in crude prices.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first quarter financial results and business updates, including, among other things, news that the Company is navigating regulatory challenges, such as the need for FDA approval for the expansion of its Raritan manufacturing facility.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Globus Medical, Inc. ("Globus Medical, Inc.") (NYSE:GMED) concerning possible violations of federal securities laws. Globus issued a press release reporting its financial results for the first quarter of 2025 On May 8, 2025.

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Informatica Inc. ("Informatica Inc.") (NYSE:INFA) concerning possible violations of federal securities laws. On February 13, 2025, Informatica issued a press release announcing its fourth quarter 2024 financial results, missing revenue forecasts and issuing disappointing fiscal 2025 guidance on the back of disappointing renewal rates.